Compare Home Depot Inc (HD) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Home Depot Inc vs Zoetis Inc — how do they compare? Home Depot Inc trades at $344.4 (market cap $353.46B), while Zoetis Inc trades at $73.61 (market cap $31.14B). The key difference: Home Depot Inc is far larger — about 11.4× Zoetis Inc's market cap, and Zoetis Inc pays the higher dividend (2.81%). Which is the better fit depends on your goals.
| HD | ZTS | |
|---|---|---|
Market Cap | $353.46B | $31.14B |
Sector | Consumer Cyclical | Health |
52-Week High | $423.42 | $156.76 |
52-Week Low | $297.51 | $71.91 |
Enterprise Value | $415.01B | $38.70B |
Dividend Yield | 2.63% | 2.81% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Home Depot (HD) trades at $347.22, down 1.01% today, with a bullish technical signal from moving averages but overbought RSI readings. Revenue grew to $159.51 billion in 2025, though net income margin declined to 8.41%. Recent earnings show mixed results, with a Q2 2026 EPS estimate of $4.73. Analyst consensus is bullish with a $371.25 price target, supported by institutional activity and a $2.33 dividend payment scheduled for June 2026.
The stock offers long-term value with strong profitability (ROE 128.38%) and analyst optimism, but faces risks from weakening housing demand and margin pressure. Upside potential exists if Pro business growth offsets macroeconomic headwinds, though high valuation multiples (P/E 25.18) warrant caution amid rising interest rates.
Zoetis (ZTS) trades at $72.42, down 3.27% amid bearish technical signals and recent earnings pressure. The stock shows strong fundamentals with 27.69% net margins and 64.91% ROE, but faces headwinds from softening pet healthcare demand. Recent Q2 2026 earnings beat estimates but revenue missed, prompting a lowered 2026 outlook. Analyst consensus remains positive with a $94.90 price target despite near-term challenges.
The outlook remains cautiously optimistic given ZTS's dominant market position and profitability, though near-term performance depends on reversing companion animal segment weakness. Investment opportunity exists at current discounted valuation (P/E 12.29), balanced against competitive pressures and class action litigation risks. Upside potential aligns with analyst targets if execution improves.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Home Depot Inc
Home Depot is the world's largest home improvement specialty retailer, operating more than 2,300 warehouse-format stores offering more than 30,000 products in store and 1 million products online in the United States, Canada, and Mexico. Its stores offer numerous building materials, home improvement products, lawn and garden products, and decor products and provide various services, including home improvement installation services and tool and equipment rentals. The acquisition of distributor Interline Brands in 2015 allowed Home Depot to enter the maintenance, repair, and operations business, which has been expanded through the tie-up with HD Supply (2020). The addition of the Company Store brought textile exposure to Home Depot's lineup.
Read more on HD →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
